glp-1 drug market size Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonist Market: Exploring
Description
doi: 10.1016/j.beem.2009.03.001
However, substantial research is needed to expand their utility, optimize delivery methods, and improve patient outcomes
THE FUTURE AND THE OTHER PEPTIDES, HORMONES AND COMPOUNDS THAT CONTROL METABOLISM Focus on GLP-1s role in prevention, reversal, and control of obesity overshadows the complex physiology of metabolizing food and regulating caloric intake
A randomized controlled trial involving 26 healthy adults showed that allulose consumption (5g) significantly reduced after-meal glucose spikes compared to sucrose controls
